| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/13/2001 | WO2001093897A2 Angiostatin and endostatin binding proteins and methods of use |
| 12/13/2001 | WO2001093882A1 Purified material having size and growth inhibitory effects on cells and tissues |
| 12/13/2001 | WO2001093861A1 Tissue specific prodrug |
| 12/13/2001 | WO2001093851A2 Compositions and methods for treating neoplastic disease using inhibitors of laminin5beta3 |
| 12/13/2001 | WO2001093805A2 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
| 12/13/2001 | WO2001093804A2 Hepatitis c virus conjugates |
| 12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
| 12/13/2001 | WO2001070968A3 Production of recombinant blood clotting factors in human cell lines |
| 12/13/2001 | WO2001055325A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055209A3 Novel human septin and uses thereof |
| 12/13/2001 | WO2001055206A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055205A8 Nucleic acids, proteins, and antibodies |
| 12/13/2001 | WO2001055103A3 Chimeric neuropeptide y receptors |
| 12/13/2001 | WO2001053335A3 Peptides with antibacterial activity |
| 12/13/2001 | WO2001046423A3 Npr1-interactors and methods of use |
| 12/13/2001 | WO2001046408A3 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes |
| 12/13/2001 | WO2001044269A3 Brain protein markers |
| 12/13/2001 | WO2001043694A3 Compositions and methods for caspase-induced apoptosis |
| 12/13/2001 | WO2001042787A3 Immunoassay for neonicotinyl insecticides |
| 12/13/2001 | WO2001042479A3 Insecticide targets and methods of use |
| 12/13/2001 | WO2001040475A3 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 12/13/2001 | WO2001040269A3 Compositions and methods for therapy and diagnosis of breast cancer |
| 12/13/2001 | WO2001040264A3 Peptide antigens |
| 12/13/2001 | WO2001037881A3 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 12/13/2001 | WO2001032852A3 Method for directed packaging of molecular substances in protein shells |
| 12/13/2001 | WO2001027136A3 Peptides which stimulate the immune response and tissue regeneration |
| 12/13/2001 | WO2001026682A3 Modified plant viruses and methods of use thereof |
| 12/13/2001 | WO2001021785A3 Megagametophyte transcriptional control elements and uses thereof |
| 12/13/2001 | WO2001021779A3 Penicillium chrysogenum transcriptional activator blar, a pathway specific regulator of beta-lactam biosynthesis, and uses therof |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | WO2001011048A3 Therapeutic polypeptides and methods for using same |
| 12/13/2001 | WO2001011038A3 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 12/13/2001 | WO2001010220A3 Insect control system |
| 12/13/2001 | WO2001004150A3 Neisseria meningitidis compounds and anti-infection applications thereof |
| 12/13/2001 | WO2000065076A3 Synthetic gene for expressing active retroviral protein in eukaryotes |
| 12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
| 12/13/2001 | WO2000029008A9 Hiv-specific t-cell induction |
| 12/13/2001 | WO2000026340A3 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 12/13/2001 | WO2000015845A9 T-type calcium channel |
| 12/13/2001 | WO2000014115A9 Mc4-r as target for the identification of compounds used to treat drug addiction |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | WO1999061634A9 Method of producing thy a-strains of vibrio cholerae, such strains and their use |
| 12/13/2001 | WO1999043783A3 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER |
| 12/13/2001 | US20010052137 Axin domain-like polypeptide inhibitors of glycogen synthase kinase 3 beta activity and activators of wnt signaling |
| 12/13/2001 | US20010051713 DNA comprising rice anther-specific gene and transgenic plant transformed therewith |
| 12/13/2001 | US20010051611 Supplying protein, antibodies, ribozymes |
| 12/13/2001 | US20010051605 Epidermal growth factor inhibitor |
| 12/13/2001 | US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation |
| 12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | US20010051358 Nucleotide sequences coding preferential pollypeptides; for use in the treatment of nervous system, vision, kidney and liver disorders; wound healing agents; anticarcinogenic agents |
| 12/13/2001 | US20010051349 Immobilization |
| 12/13/2001 | US20010051336 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles |
| 12/13/2001 | US20010051335 Nucleotide sequences for use in the detection, evaluation and development of disease resistant plants |
| 12/13/2001 | US20010051163 Providing an impure aqueous solution of pertactin free from pertussis toxin (PT) and filamentous haemagglutinin (FHH), purifying by passing the solution with a particulate ion-exchange medium, subjection to ultrafiltration |
| 12/13/2001 | US20010051153 Grampositive bacteria; gastrointestinal disorders |
| 12/13/2001 | US20010051146 Agent for preventing and/or treating multiple organ failure |
| 12/13/2001 | DE10113781A1 New DNA encoding synthetic spider silk protein, useful e.g. for closing wounds, comprises modules that encode repeating units of spirodoin proteins |
| 12/13/2001 | DE10028725A1 Primary structure and nucleic acid of the human neutrophil antigen-2a, useful for antigen detection, e.g. diagnosis of various forms of neutropenia |
| 12/13/2001 | DE10027777A1 Introducing substances into cells of sensory organs, useful for treating degenerative disorders of ear and eye, uses penetratin as transporter molecule |
| 12/13/2001 | DE10027705A1 Separation of membrane proteins, useful for proteosome analysis, by attaching membranes to carrier then performing electrophoretic migration |
| 12/13/2001 | DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control |
| 12/13/2001 | DE10026520A1 New fluorescent or colored proteins from Anemonia sulcata, useful as markers in molecular biology and genetic engineering |
| 12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591630A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2585822A1 Breast, rectal, colon and lung tumour marker pro19628 polypeptide and encoding nucleic acid |
| 12/13/2001 | CA2414076A1 Multivalent platform molecules comprising high molecular weight polyethylene oxide |
| 12/13/2001 | CA2414061A1 Metalloprotease peptide substrates and methods |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411730A1 Tumour suppressor and uses thereof |
| 12/13/2001 | CA2411719A1 Novel g-protein coupled receptor |
| 12/13/2001 | CA2411684A1 Method for electrophoretically separating membrane proteins |
| 12/13/2001 | CA2411609A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | CA2411600A1 Synthetic spider silk proteins and the expression thereof in transgenic plants |
| 12/13/2001 | CA2411578A1 Adjuvant composition comprising fha protein or fragment of fha protein in free form |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2411439A1 Tyrosine kinase modulators |
| 12/13/2001 | CA2411354A1 Methods of treating viral diseases with il-18 and il-18 combinations |
| 12/13/2001 | CA2411101A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 12/13/2001 | CA2411072A1 Method to detect modulators of vegf kinase domain |
| 12/13/2001 | CA2411069A1 The human voltage gated sodium channel .beta.-1a subunit and methods of use |
| 12/13/2001 | CA2411067A1 Oligopeptides for promoting hair growth |
| 12/13/2001 | CA2411017A1 Epididymis-specific proteins with fibronectin type ii modules |
| 12/13/2001 | CA2410938A1 Recombinant subunit proteins from porcine parvovirus produced in plants |
| 12/13/2001 | CA2410512A1 Recombinant aav vectors for gene therapy of obesity |
| 12/13/2001 | CA2410162A1 Breast, rectal, colon and lung tumor marker pro 4332 polypeptide and encoding nucleic acid |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/13/2001 | CA2409287A1 Hepatitis c virus conjugates |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/13/2001 | CA2407551A1 Cis-zeatin glucosyl transferase from zea mays |
| 12/13/2001 | CA2381249A1 Methods and compositions for modulating oxidized ldl transport |
| 12/12/2001 | EP1162458A1 Methods and compositions for modulating oxidized LDL transport |
| 12/12/2001 | EP1162276A2 MRNA molecules to be used as indicators of the functional and activational state of T-lymphocytes |
| 12/12/2001 | EP1162273A1 Recombinant DNA vectors for gene therapy |